| First Author | Xie N | Year | 2017 |
| Journal | Nat Commun | Volume | 8 |
| Pages | 16016 | PubMed ID | 28799539 |
| Mgi Jnum | J:252785 | Mgi Id | MGI:5927114 |
| Doi | 10.1038/ncomms16016 | Citation | Xie N, et al. (2017) SRSF1 promotes vascular smooth muscle cell proliferation through a Delta133p53/EGR1/KLF5 pathway. Nat Commun 8:16016 |
| abstractText | Though vascular smooth muscle cell (VSMC) proliferation underlies all cardiovascular hyperplastic disorders, our understanding of the molecular mechanisms responsible for this cellular process is still incomplete. Here we report that SRSF1 (serine/arginine-rich splicing factor 1), an essential splicing factor, promotes VSMC proliferation and injury-induced neointima formation. Vascular injury in vivo and proliferative stimuli in vitro stimulate SRSF1 expression. Mice lacking SRSF1 specifically in SMCs develop less intimal thickening after wire injury. Expression of SRSF1 in rat arteries enhances neointima formation. SRSF1 overexpression increases, while SRSF1 knockdown suppresses the proliferation and migration of cultured human aortic and coronary arterial SMCs. Mechanistically, SRSF1 favours the induction of a truncated p53 isoform, Delta133p53, which has an equal proliferative effect and in turn transcriptionally activates Kruppel-like factor 5 (KLF5) via the Delta133p53-EGR1 complex, resulting in an accelerated cell-cycle progression and increased VSMC proliferation. Our study provides a potential therapeutic target for vascular hyperplastic disease. |
